Primary Care Clinics in Cambria Heights, NY Accepting Medicare
7 Primary Care Clinics found. Showing 1 - 7
 East Queens Medical Diagnostic Services, Pc Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 23011 Linden Blvd, Cambria Heights, NY 11411 Phone: 718-276-3400 Fax: 718-276-3402 |
Caricare Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 23011 Linden Blvd, Cambria Heights, NY 11411 Phone: 718-276-3400 Fax: 718-276-3402 |
The Vine Np Family Health Pllc Clinic/Center Medicare: Medicare Enrolled Practice Location: 11944 218th St, Cambria Heights, NY 11411 Phone: 347-445-2284 |
Cambria Health Medical, P.c. Internal Medicine Medicare: Medicare Enrolled Practice Location: 11751 220th St, Cambria Heights, NY 11411 Phone: 718-723-4303 |
Caribe Medical Pc Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 23011 Linden Blvd, Cambria Heights, NY 11411 Phone: 718-276-3400 Fax: 718-276-3402 |
Lyrico Llc Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 11918 223rd St, Cambria Heights, NY 11411 Phone: 191-785-50146 |
Camcare Medical Internal Medicine Medicare: Medicare Enrolled Practice Location: 22806 Linden Blvd, Cambria Heights, NY 11411 Phone: 718-712-1219 Fax: 718-712-1217 |
News Archive
Ireland's Health Research Board awards €1.2M to UL researchers
University of Limerick researchers have been awarded over €1.2 million funding by Ireland's Health Research Board. The funding will support health research focused on; primary care reform in Ireland; avoidance of adverse outcomes in vascular surgery; dealing with the progression of chronic kidney disease and enhancing physical activity for multiple sclerosis patients.
Boehringer Ingelheim, Lilly receive FDA approval for Jentadueto to treat type 2 diabetes
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) has approved Jentadueto (linagliptin/metformin hydrochloride) tablets, a new tablet combining the dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, and metformin.
BSI implements plans to expand its medical device Notified Body scope to include IVD devices
BSI, a world-class Notified Body providing regulatory and quality management reviews and product certification for medical devices, is rapidly implementing plans to expand its medical device Notified Body scope to include in vitro diagnostic (IVD) devices.
World's fastest supercomputer identifies chemicals with potential to stop COVID-19
What makes the coronavirus disease (COVID-19) global pandemic different from the Spanish flu in 1918? In 1918, transportation, technology, and science were in their infancy, with the medical field not capable of fighting outbreaks. Technology has come a long way, within days, scientists have already identified the type of virus spreading in China, and three months after, vaccine trials have started.
› Verified 6 days ago